Objective: To explore the genetic basis for a patient with unexplained developmental delay and special facial features.
Methods: A male patient admitted to the Maternal and Child Health Care Hospital of Gansu Province on May 27, 2021 due to infertility was selected as the study subject. Clinical data of the patient was collected, and genomic DNA was extracted from peripheral blood samples from the patient and his parents. Whole exome sequencing (WES) was carried out, and candidate variant was verified by Sanger sequencing.
Results: The patient was found to harbor a 2.54 Mb deletion in 1p36.33p36.32 and a heterozygous c.1123G>C (p.E375Q) variant of the CHD3 gene, neither of which was detected in his parents.
Conclusion: The patient was diagnosed with Snijders Blok-Campeau syndrome in conjunct with 1p36 deletion syndrome, which has enabled genetic counseling for his family.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3760/cma.j.cn511374-20230108-00016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Segmental chromosome aberrations as a prognostic factor of neuroblastoma: a meta-analysis and systematic review.
Transl Pediatr
October 2024
Department of General Surgery, Children's Hospital of Hebei Province, Shijiazhuang, China.
Background: Segmental chromosome aberrations, defined as presence of aberrations, deletion, or imbalance in the chromosomal arms, have long been considered as a predictor of poor prognosis of patients with neuroblastoma. The objective of this meta-analysis is to quantitively analyze the hazard ratios (HRs) of different whole or segmental chromosome aberrations for overall survival (OS) rate or event-free survival (EFS) rate of patients with neuroblastoma.
Methods: Relevant studies about chromosome, neuroblastoma, predictor, prognosis, and survival published from the inception to April 2023 in the databases of PubMed, Embase, and Web of Science were searched, screened, and reviewed.
First-trimester application of expanded non-invasive prenatal testing in the genetic investigation of fetal 1p36 deletion syndrome associated with a familial unbalanced reciprocal translocation of 46,XX,der(1)t(1;2) (p36.2;q37.3)dmat.
Taiwan J Obstet Gynecol
November 2024
Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
Article Synopsis
- A case study discussed the use of expanded non-invasive prenatal testing (NIPT) to detect 1p36 deletion syndrome in a 37-year-old woman undergoing pregnancy via in vitro fertilization.* -
- The NIPT was positive for a genetic issue at 13 weeks, but tragically, the pregnancy ended with intrauterine fetal death after a follow-up amniocentesis, which confirmed chromosomal abnormalities.* -
- The findings highlight the efficacy of NIPT for early detection of genetic disorders, specifically familial unbalanced reciprocal translocation, which can aid in prenatal genetic counseling.*
DNA methylation dysregulation patterns in the 1p36 region instability.
J Appl Genet
October 2024
Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
In the monosomy 1p36 deletion syndrome, the role of DNA methylation in the genomic stability of the 1p36 region remains elusive. We hypothesize that changes in the methylation pattern at the 1p36 breakpoint hotspot region influenced the chromosomal breakage leading to terminal deletions. From the monosomy 1p36 material collection, four cases with 4.
View Article and Find Full Text PDFMachine learning-based new classification for immune infiltration of gliomas.
PLoS One
October 2024
Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Background: Glioma is a highly heterogeneous and poorly immunogenic malignant tumor, with limited efficacy of immunotherapy. The characteristics of the immunosuppressive tumor microenvironment (TME) are one of the important factors hindering the effectiveness of immunotherapy. Therefore, this study aims to reveal the immune microenvironment (IME) characteristics of glioma and predict different immune subtypes using machine learning methods, providing guidance for immune therapy in glioma.
View Article and Find Full Text PDFClinical Features of a Japanese Girl With Radio-Tartaglia Syndrome due to a SPEN Truncating Variant.
Am J Med Genet A
October 2024
Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
Radio-Tartaglia syndrome (RATARS) (MIM#619312) is a genetic disorder caused by heterozygous truncating variants of SPEN on chromosome 1p36. This syndrome is extremely rare, with only 34 cases reported to date. RATARS is characterized by developmental delay, hypotonia, and intellectual disability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!